Literature DB >> 12182883

Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning.

J W Smith1, L A Fetsko, R Xu, Y Wang.   

Abstract

The dopamine D2 receptor (D2) is implicated in drug addiction, learning and memory. Two isoforms of the D2 receptor, termed D2L (long form) and D2S (short form), have been identified. We previously generated mice lacking D2L (D2L-/-), but expressing functional D2S. In this study, we investigated the role of D2L in the positive and negative reinforcing properties of abused drugs and electrical stimuli, using D2L-/- mice as a model system. Mice were trained in three associative learning tasks: conditioned place preference to morphine and cocaine, conditioned place aversion to naloxone-precipitated morphine withdrawal, and active avoidance. D2L-/- mice, like wild type mice, developed a place preference to cocaine. In contrast to wild type mice, D2L-/- mice did not develop a place preference to morphine, nor did they attain a place aversion to morphine withdrawal. D2L-/- mice also failed to acquire avoidance behavior in response to electrical stimuli. There were no significant differences between D2L-/- and wild type mice in mu-opioid receptor density, morphine-induced locomotor stimulation and morphine withdrawal symptoms. These results suggest that D2L may have a greater impact than D2S on the rewarding aspects of morphine, and the aversive properties of morphine withdrawal and electrical stimulus. These findings also suggest that the presence of D2L is critical in the acquisition (learning) and/or retention (memory) of context-stimulus associations in certain situations. On the other hand, D2L is not essential for the rewarding aspects of cocaine and for the development of morphine dependence. Thus, these studies reveal distinct functional roles of D2L and/or D2S in drug addiction and avoidance learning, which may lead to a better understanding of the neurobiological basis underlying these behaviors. Copyright 2002 IBRO

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12182883     DOI: 10.1016/s0306-4522(02)00257-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  28 in total

1.  A single cocaine exposure enhances both opioid reward and aversion through a ventral tegmental area-dependent mechanism.

Authors:  Joseph A Kim; Kelly A Pollak; Gregory O Hjelmstad; Howard L Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-02       Impact factor: 11.205

2.  Morphine-conditioned single-trial place preference: role of nucleus accumbens shell dopamine receptors in acquisition, but not expression.

Authors:  Sandro Fenu; Liliana Spina; Emilia Rivas; Rosanna Longoni; Gaetano Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  2006-05-25       Impact factor: 4.530

3.  Effects of activation and blockade of dopamine receptors on the extinction of a passive avoidance reaction in mice with a depressive-like state.

Authors:  N I Dubrovina; D V Zinov'eva
Journal:  Neurosci Behav Physiol       Date:  2009-12-11

4.  Effects of pramipexole on the acquisition of responding with opioid-conditioned reinforcement in the rat.

Authors:  Jeremiah W Bertz; Jianyong Chen; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2014-07-03       Impact factor: 4.530

5.  DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience.

Authors:  Marta Peciña; Brian J Mickey; Tiffany Love; Heng Wang; Scott A Langenecker; Colin Hodgkinson; Pei-Hong Shen; Sandra Villafuerte; David Hsu; Sara L Weisenbach; Christian S Stohler; David Goldman; Jon-Kar Zubieta
Journal:  Cortex       Date:  2012-02-14       Impact factor: 4.027

6.  Pathway-specific modulation of nucleus accumbens in reward and aversive behavior via selective transmitter receptors.

Authors:  Takatoshi Hikida; Satoshi Yawata; Takashi Yamaguchi; Teruko Danjo; Toshikuni Sasaoka; Yanyan Wang; Shigetada Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

7.  Adenosine A1 and A2A receptors are not upstream of caffeine's dopamine D2 receptor-dependent aversive effects and dopamine-independent rewarding effects.

Authors:  Jessica E Sturgess; Ryan A Ting-A-Kee; Dominik Podbielski; Laurie H L Sellings; Jiang-Fan Chen; Derek van der Kooy
Journal:  Eur J Neurosci       Date:  2010-06-22       Impact factor: 3.386

8.  The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction.

Authors:  Toni-Kim Clarke; Amy R D Weiss; Thomas N Ferarro; Kyle M Kampman; Charles A Dackis; Helen M Pettinati; Charles P O'brien; David W Oslin; Falk W Lohoff; Wade H Berrettini
Journal:  Ann Hum Genet       Date:  2013-11-25       Impact factor: 1.670

9.  Brain stimulation and morphine reward deficits in dopamine D2 receptor-deficient mice.

Authors:  G I Elmer; J O Pieper; J Levy; M Rubinstein; M J Low; D K Grandy; R A Wise
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

10.  Role of dopamine D2 receptors in plasticity of stress-induced addictive behaviours.

Authors:  Hye-Ri Sim; Tae-Yong Choi; Hyo Jin Lee; Eun Young Kang; Sehyoun Yoon; Pyung-Lim Han; Se-Young Choi; Ja-Hyun Baik
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.